Arbuck S - Search Results

1

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. Eisenhauer EA, et al. Among authors: arbuck s. Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026. Eur J Cancer. 2009. PMID: 19097774

2

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. Therasse P, et al. Among authors: arbuck sg. J Natl Cancer Inst. 2000 Feb 2;92(3):205-16. doi: 10.1093/jnci/92.3.205. J Natl Cancer Inst. 2000. PMID: 10655437

3

Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF.

Ford PA, Arbuck SG, Minniti C, Miller LL, DeMaria D, O'Dwyer PJ. Ford PA, et al. Among authors: arbuck sg. Eur J Cancer. 1996 Apr;32A(4):631-5. doi: 10.1016/0959-8049(95)00602-8. Eur J Cancer. 1996. PMID: 8695266 Clinical Trial.

4

A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.

Moulder SL, Holmes FA, Tolcher AW, Thall P, Broglio K, Valero V, Buzdar AU, Arbuck SG, Seidman A, Hortobagyi GN. Moulder SL, et al. Among authors: arbuck sg. Cancer. 2010 Feb 15;116(4):814-21. doi: 10.1002/cncr.24870. Cancer. 2010. PMID: 20052721 Free PMC article. Clinical Trial.

5

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.

Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA. Johnson JI, et al. Among authors: arbuck s. Br J Cancer. 2001 May 18;84(10):1424-31. doi: 10.1054/bjoc.2001.1796. Br J Cancer. 2001. PMID: 11355958 Free PMC article.

6

Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke.

Friedman HS, Kerby T, Fields S, Zilisch JE, Graden D, McLendon RE, Houghton PJ, Arbuck S, Cokgor I, Friedman AH. Friedman HS, et al. Among authors: arbuck s. Cancer. 1999 Mar 1;85(5):1160-5. Cancer. 1999. PMID: 10091802 Clinical Trial.

7

Seizures associated with leucovorin administration in cancer patients.

Meropol NJ, Creaven PJ, Petrelli NJ, White RM, Arbuck SG. Meropol NJ, et al. Among authors: arbuck sg. J Natl Cancer Inst. 1995 Jan 4;87(1):56-8. doi: 10.1093/jnci/87.1.56. J Natl Cancer Inst. 1995. PMID: 7666465 No abstract available.

8

National Cancer Institute Clinical Trials Program in Colorectal Cancer.

Conley BA, Kaplan RS, Arbuck SG. Conley BA, et al. Among authors: arbuck sg. Cancer Chemother Pharmacol. 1998;42 Suppl:S75-9. doi: 10.1007/s002800051084. Cancer Chemother Pharmacol. 1998. PMID: 9750034 Review.

9

Clinical development of Taxol.

Arbuck SG, Christian MC, Fisherman JS, Cazenave LA, Sarosy G, Suffness M, Adams J, Canetta R, Cole KE, Friedman MA. Arbuck SG, et al. J Natl Cancer Inst Monogr. 1993;(15):11-24. J Natl Cancer Inst Monogr. 1993. PMID: 7912517 Review.

10

An overview of topoisomerase I-targeting agents.

Arbuck SG, Takimoto CH. Arbuck SG, et al. Semin Hematol. 1998 Jul;35(3 Suppl 4):3-12. Semin Hematol. 1998. PMID: 9779876 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results